Article content
OTTAWA Canada could have done more to boost homegrown COVID-19 vaccines last spring but the federal government and its agencies were too slow and risk-averse when it came to funding, a parliamentary committee heard Monday.
John Lewis, CEO of Entos Pharmaceuticals, said his Alberta company has a vaccine candidate in development but never received the kind of early, up-front funding that the U.S. and U.K. governments put into their own vaccine production.
We apologize, but this video has failed to load.
Try refreshing your browser, or Canada was too slow and risk-averse in funding domestic vaccine candidates, MPs told Back to video
Canada missed chance to help homegrown vaccines move quickly last spring: developers | iNFOnews
infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.
Le Canada a échoué à soutenir les candidats vaccins canadiens, disent des concepteurs
lactualite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lactualite.com Daily Mail and Mail on Sunday newspapers.
Candidats-vaccins canadiens | Ottawa n a pas assez financé au début de la pandémie, disent des développeurs
lapresse.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lapresse.ca Daily Mail and Mail on Sunday newspapers.
Canada was too slow and risk-averse in funding domestic vaccine candidates, MPs told
windsorstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from windsorstar.com Daily Mail and Mail on Sunday newspapers.